| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043494035 |
| P356 | DOI | 10.1038/MP.2011.170 |
| P698 | PubMed publication ID | 22182936 |
| P2093 | author name string | W Wang | |
| E Kwon | |||
| L-H Tsai | |||
| P2860 | cites work | Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling | Q24322974 |
| Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. | Q24535773 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| Whole-genome association study of bipolar disorder | Q28271419 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors | Q35995825 | ||
| Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain | Q48217502 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 11-12 | |
| P577 | publication date | 2011-12-20 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | |
| P478 | volume | 18 |
| Q63869261 | A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data |
| Q36994815 | A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression |
| Q92602807 | A VNTR Regulates miR-137 Expression Through Novel Alternative Splicing and Contributes to Risk for Schizophrenia |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q39026765 | A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. |
| Q48348498 | A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity |
| Q34657883 | A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder |
| Q42753490 | A survey of rare coding variants in candidate genes in schizophrenia by deep sequencing. |
| Q64112322 | Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients |
| Q37120426 | Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex |
| Q34177537 | Association of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population. |
| Q47828457 | Association study of schizophrenia with variants in miR-137 binding sites. |
| Q34458640 | Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis |
| Q38189850 | Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. |
| Q89113653 | Building a schizophrenia genetic network: transcription factor 4 regulates genes involved in neuronal development and schizophrenia risk |
| Q40643280 | CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector |
| Q37710652 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells |
| Q35369598 | Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. |
| Q60923952 | Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells |
| Q39127101 | Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population. |
| Q35731566 | Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets |
| Q38384194 | Determining the role of microRNAs in psychiatric disorders |
| Q41819484 | Dissection of allelic interactions among Pto-miR257 and its targets and their effects on growth and wood properties in Populus |
| Q93047581 | Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling |
| Q35553863 | Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. |
| Q50419804 | Dysregulation of miRNA and its potential therapeutic application in schizophrenia. |
| Q64076067 | Epigenetic Regulations in Neuropsychiatric Disorders |
| Q37496956 | Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders |
| Q33924728 | Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. |
| Q47957465 | Exposure to PM2.5 causes genetic changes in fetal rat cerebral cortex and hippocampus |
| Q36837420 | Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals |
| Q89599083 | Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders |
| Q35974121 | Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip |
| Q40676388 | Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis |
| Q33949729 | Genetic architectures of psychiatric disorders: the emerging picture and its implications |
| Q34603780 | Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia |
| Q38268606 | Genetics in psychiatry |
| Q21261478 | Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1 |
| Q97527612 | Genome-wide identification of methylated CpG sites in nongenital cutaneous warts |
| Q37505070 | Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells |
| Q93212905 | Genomic updates in understanding PTSD |
| Q38262765 | Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. |
| Q95579811 | Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics |
| Q34447816 | Heterogeneity and individuality: microRNAs in mental disorders |
| Q38751829 | Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus. |
| Q33635688 | Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder. |
| Q52326263 | MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. |
| Q38989183 | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets |
| Q35489742 | Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk |
| Q39002120 | MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q41554837 | MiRNAs of peripheral blood as the biomarker of schizophrenia |
| Q58785403 | Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells |
| Q35691087 | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. |
| Q37992401 | MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction |
| Q38227729 | MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites |
| Q37363559 | MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients |
| Q39185826 | MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia |
| Q33676705 | MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant |
| Q34394249 | MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review |
| Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
| Q38033846 | MicroRNAs shape the neuronal landscape |
| Q26744819 | MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases |
| Q33627250 | Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia |
| Q30442237 | Neurodevelopment in schizophrenia: the role of the wnt pathways |
| Q90114172 | Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development |
| Q36067795 | No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population. |
| Q34578760 | No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure |
| Q26851626 | Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease |
| Q92813967 | Novel Approaches for Identifying the Molecular Background of Schizophrenia |
| Q38103810 | Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. |
| Q90406392 | Polymorphism in schizophrenia risk gene MIR137 is associated with the posterior cingulate Cortex's activation and functional and structural connectivity in healthy controls |
| Q36915423 | Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia |
| Q30454963 | Potential Impact of miR-137 and Its Targets in Schizophrenia |
| Q42934154 | Puzzling over schizophrenia: schizophrenia as a pathway disease |
| Q38260258 | Recent genetic findings in schizophrenia and their therapeutic relevance |
| Q35596962 | Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation |
| Q38057999 | TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease |
| Q94517766 | TS: a powerful truncated test to detect novel disease associated genes using publicly available gWAS summary data |
| Q52148949 | The Multifarious Hippocampal Functions of MicroRNA-137. |
| Q48140110 | The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia |
| Q34381708 | The genomics of schizophrenia: update and implications. |
| Q33923604 | The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects |
| Q41002359 | The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. |
| Q91945137 | The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia |
| Q38450466 | The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function. |
| Q27312392 | The schizophrenia risk gene product miR-137 alters presynaptic plasticity. |
| Q58730340 | Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells |
| Q38177652 | Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. |
| Q37706529 | Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells |
| Q38979078 | Transcriptional targets of the schizophrenia risk gene MIR137. |
| Q35079675 | Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder |
| Q33940022 | Transcriptome-wide discovery of microRNA binding sites in human brain. |
| Q92286637 | Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles |
| Q35533016 | ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin |
| Q38957856 | miR-137, a new target for post-stroke depression? |
| Q98182369 | miR-137: A Novel Therapeutic Target for Human Glioma |
| Q37645440 | miR-137: a new player in schizophrenia |
| Q92187683 | miRNA-Dependent Control of Homeostatic Plasticity in Neurons |
| Q36463734 | miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome |
| Q60958314 | microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease |
Search more.